Delivery Order SPE2DR25D6028-SPE2DR26FAQRR
Award Date 10/20/25
Potential Completion Date 11/10/25
Potential Value $25K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $11,624.35 delivery order to AmerisourceBergen Drug Corp for the supply of Lorbrena 100 mg tablets (30-count packages) under a firm fixed-price contract. The delivery order is scheduled for completion by September 18, 2025, and will be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania facility. This award was competitively awarded with no set-aside designation, reflecting the vendor's capability to meet federal pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Lorbrena 100 mg tablets (30-count) valued at $11,624.35. This firm fixed-price delivery order, awarded on August 21, 2025, is scheduled for completion by September 12, 2025, with performance at the vendor's Conshohocken facility. The award represents a non-competitive, non-set-aside transaction, indicating it was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Lorbrena 25 mg tablets (30-count units) valued at $11,624.34. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award under open market conditions. The contract is scheduled for completion by October 8, 2025, with performance to be fulfilled from the contractor's location in Conshohocken, Pennsylvania. This award represents...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Lorbrena 100 mg tablets in quantities of 30. This firm fixed-price delivery order, valued at $11,624.35, represents a competitive award with no set-aside designation and is scheduled for completion by September 16, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Lorbrena 100mg tablets in quantities of 30 units. This firm fixed price delivery order, valued at $23,248.70, is scheduled for completion by August 11, 2025, with performance to be executed at the contractor's Conshohocken, Pennsylvania location. The award was made on a competitive basis with no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a $11,624.35 delivery order to AmerisourceBergen Drug Corp for the supply of Lorbrena 100 mg tablets (30-count units) with a firm fixed price structure and an ultimate completion date of October 14, 2025. This non-set-aside, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement valued through December 2026....
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $23,248.72 on September 5, 2025, for the supply of Lorbrena 100 mg tablets (30-count units). This firm fixed-price, competitively awarded contract carries an ultimate completion date of September 26, 2025, and involves performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The award contains no set-aside designation, reflecting AmerisourceBergen's...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a leading global pharmaceutical distribution company. The contract, valued at $10,578.39, is for the delivery of 4564002715 - LORBRENA 100 MG TABLET 30S, a specialty pharmaceutical product. The award has an ultimate completion date of April 8, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,688.62 firm fixed-price delivery order is for the supply of LORBRENA 100MG TAB 30S, a pharmaceutical product. The contract has an ultimate completion date of April 23, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LORBRENA 100MG TAB 30S, a pharmaceutical product, with a ceiling value of $22,688.62 and a period of performance through March 19, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition....